Tag: Drug cost

The annual list price for the cystic fibrosis medication Trikafta can exceed $300,000, but this figure does not reflect what most patients actually pay out-of-pocket. Understanding **how much does Trikafta cost for cystic fibrosis patients** is crucial, as the final expense is influenced heavily by insurance coverage and financial assistance programs.

Without insurance, the list price for a one-month supply of the brand-name medication OFEV (nintedanib) can exceed $14,000. For those with insurance, the out-of-pocket expenses vary significantly, though manufacturer programs can help reduce costs for eligible patients to as little as $0 per month. Understanding the different financial avenues is crucial for managing the cost of this vital medication.

With a list price of approximately $2,300 per treatment as of early 2025, many patients and healthcare providers ask: why does Vabysmo cost so much?. The answer lies in the complex ecosystem of pharmaceutical pricing, which includes everything from advanced research and development to market competition and distribution costs.

In clinical studies, adding Leqvio to a statin lowered bad cholesterol (LDL-C) by about 50% [1.8.3]. So, how much is a shot of Leqvio? The list price is approximately $3,587.73 per dose, but patient costs are often much lower [1.2.1].

Approximately 50% of melanoma patients have a BRAF V600 protein kinase mutation, a target for specific therapies [1.2.1]. For these patients, understanding 'How much does vemurafenib cost in the US?' is a critical part of managing their treatment journey and financial planning.

With an annual list price of approximately $49,000, Litfulo (ritlecitinib) can appear prohibitively expensive, but the final out-of-pocket cost for patients varies widely based on insurance and financial aid. Understanding **what is the price of Litfulo Ritlecitinib** requires delving into how the sticker price differs from what most patients actually pay.

Following its full FDA approval in July 2024, Eli Lilly's Alzheimer's treatment, Kisunla (donanemab), was launched with a list price of $32,000 for a year of treatment. The final cost to patients for this disease-modifying therapy can vary significantly based on treatment duration, insurance coverage, and additional monitoring requirements.

The list price for a one-month supply of Dupixent is approximately $3,993, but this is rarely the final cost for patients. Understanding **how much does Dupixent cost for COPD** requires navigating insurance plans, assistance programs, and various discount options.

ARIKAYCE (amikacin liposome inhalation suspension) was first approved by the FDA on September 28, 2018 [1.2.5]. Currently, **is there a generic for ARIKAYCE?** No, ARIKAYCE is only available as a brand-name medication and does not have a generic version [1.2.1, 1.3.4].

A 30-day supply of the brand-name prescription drug Glyxambi can cost hundreds of dollars without insurance, as there is currently no lower-priced generic version available in the United States. This raises the question for many patients: **Does Glyxambi have a generic?** and what are the options for controlling costs in the meantime?